Search - tctmd.com

Displaying 221 - 240 of 307

Sort: Relevancy | Date

News Daily News

Drug-Eluting Balloon Provides Strong Primary Patency in SFA at 1 Year

April 14, 2014

News Daily News

Los Balones liberadores de Fármacos Reducen la Reestenosis y la RLD en Pacientes Diabéticos con ICE

Yael L. Maxwell

February 26, 2014

News Daily News

Drug-Eluting Balloons Reduce Restenosis, TLR in Diabetic Patients with CLI

Yael L. Maxwell

February 26, 2014

Presentation

DEB vs. Standard Angioplasty to Reduce Recurrent Restenosis in Diabetics with Femoropopliteal ISR

Presenter: Francesco Liistro

February 24, 2014

News Industry News

Zilver PTX randomized trial of paclitaxel-eluting stents for femoropopliteal disease demonstrates superior results

February 13, 2014

News Daily News

STROLL at 3 Years: Nitinol Stent Demonstrates Sustained Patency, QoL in SFA Patients

L.A. McKeown

January 20, 2014

Presentation TCT 2013

LEVANT 2: A Prospective, Randomized Trial of a Paclitaxel-Coated Balloon vs. Standard Balloon Angioplasty in Diseased Femoropopliteal Arteries

Presenter: Kenneth Rosenfield

October 30, 2013

News Industry News

New Study Examines Safety and Efficacy of Drug Coated Balloon Angioplasty for Treatment of Femoropopliteal Artery Disease

October 30, 2013

News Conference News TCT 2013

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

October 30, 2013

Presentation TCT 2013

TCT-132. Prospective, Multicenter Tack Optimized Balloon Angioplasty (TOBA) Study for Femoropopliteal Arteries Using the Tack-IT Endovascular SystemTM

Presenter: Koen Deloose

October 28, 2013

Presentation TCT 2013

The Global Effect of Zilver PTX on Management of Femoropopliteal Disease

Presenter: Michael Dake

October 27, 2013

Presentation TCT 2013

Update on Percutaneous Femoropopliteal Bypass: The Next Evolutionary Step in SFA Treatment?

Presenter: James Joye

October 27, 2013

News Industry News

Boston Scientific Reports Favorable Clinical Trial Results Assessing The OffRoad™ Re-Entry Catheter System

October 11, 2013

Presentation Scripps 2013

Optimal Treatment of the Femoropopliteal Segment: Tips, Tricks and Device Selection

Presenter: John R. Laird

October 03, 2013

News Daily News

La Reestenosis Intracraneal Intra Stent acarrea un Mayor Riesgo de sufrir Episodios Isquémicos

Yael L. Maxwell

August 30, 2013

News Daily News

Intracranial In-Stent Restenosis Leads to Higher Risk of Recurrent Ischemic Events

Yael L. Maxwell

August 30, 2013

News Daily News

Patency Higher, Reintervention Lower with Stenting vs. Surgery in PAD

August 12, 2013

News Daily News

Un Stent Recubierto Resulta Prometedor en el Tratamiento de Lesiones Largas de la AFS

L.A. McKeown

July 19, 2013

News Daily News

Covered Stent Shows Promise in Treating Long SFA Lesions

L.A. McKeown

July 19, 2013

News Daily News

Los Balones liberadores de Fármacos Reducen la RLD en Diabéticos con Isquemia Crítica de las Extremidades

Jason Kahn

July 05, 2013

Advertisement

Drug-Eluting Balloon Provides Strong Primary Patency in SFA at 1 Year

Los Balones liberadores de Fármacos Reducen la Reestenosis y la RLD en Pacientes Diabéticos con ICE

Drug-Eluting Balloons Reduce Restenosis, TLR in Diabetic Patients with CLI

DEB vs. Standard Angioplasty to Reduce Recurrent Restenosis in Diabetics with Femoropopliteal ISR

Zilver PTX randomized trial of paclitaxel-eluting stents for femoropopliteal disease demonstrates superior results

STROLL at 3 Years: Nitinol Stent Demonstrates Sustained Patency, QoL in SFA Patients

LEVANT 2: A Prospective, Randomized Trial of a Paclitaxel-Coated Balloon vs. Standard Balloon Angioplasty in Diseased Femoropopliteal Arteries

New Study Examines Safety and Efficacy of Drug Coated Balloon Angioplasty for Treatment of Femoropopliteal Artery Disease

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

TCT-132. Prospective, Multicenter Tack Optimized Balloon Angioplasty (TOBA) Study for Femoropopliteal Arteries Using the Tack-IT Endovascular SystemTM

The Global Effect of Zilver PTX on Management of Femoropopliteal Disease

Update on Percutaneous Femoropopliteal Bypass: The Next Evolutionary Step in SFA Treatment?

Boston Scientific Reports Favorable Clinical Trial Results Assessing The OffRoad™ Re-Entry Catheter System

Optimal Treatment of the Femoropopliteal Segment: Tips, Tricks and Device Selection

La Reestenosis Intracraneal Intra Stent acarrea un Mayor Riesgo de sufrir Episodios Isquémicos

Intracranial In-Stent Restenosis Leads to Higher Risk of Recurrent Ischemic Events

Patency Higher, Reintervention Lower with Stenting vs. Surgery in PAD

Un Stent Recubierto Resulta Prometedor en el Tratamiento de Lesiones Largas de la AFS

Covered Stent Shows Promise in Treating Long SFA Lesions

Los Balones liberadores de Fármacos Reducen la RLD en Diabéticos con Isquemia Crítica de las Extremidades

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content